483
Banji Awosika, M.D.Banji Awosika, M.D. – FDA 483, Jan 27, 2023
Record Details
An FDA inspection of Banji Awosika, M.D. in Orlando, FL, a clinical investigator, revealed significant deviations from the investigational plan. The firm failed to ensure subjects were dosed only after complete safety lab review and did not properly document adjusted glomerular filtration rate (aGFR) calculations. These failures led to the enrollment of subjects who did not meet study entry criteria.
View Company Profile
ID · 69089dd8-30f8-4e12-b5fc-f457e60c1807
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.